Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms.
about
Analysis of HLA DR, HLA DQ, C4A, FcgammaRIIa, FcgammaRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcgammaRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibilityAlloantibody Generation and Effector Function Following Sensitization to Human Leukocyte AntigenGenomic organization of classical human low-affinity Fcgamma receptor genes.FcgammaRIIa/IIIa polymorphism and its association with clinical manifestations in Korean lupus patients.Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.Fcgamma receptors: structure, function and role as genetic risk factors in SLELack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4-deficient patients with systemic lupus erythematosus (SLE).Functions of the Fc receptors for immunoglobulin G.Lupus susceptibility genes on human chromosome 1.The genetics of systemic lupus erythematosus: putting the pieces together.A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31Biomarker profiling for lupus nephritis.Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.Fcgamma receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms.Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.The candidate gene approach: have murine models informed the study of human SLE?Hydrodynamic delivery of plasmid DNA encoding human FcγR-Ig dimers blocks immune-complex mediated inflammation in miceTargeting Syk as a treatment for allergic and autoimmune disorders.Gene polymorphisms and periodontitis.Defective Fc-dependent processing of immune complexes in patients with systemic lupus erythematosus.Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus.Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse.FcgammaRIIa polymorphism in Japanese patients with systemic lupus erythematosus.Genetic susceptibility to lupus nephritis.Systemic lupus erythematosus candidate genes in the Italian population: evidence for a significant association with interleukin-10Immune complex processing in C1q-deficient miceGenetic linkage and association of Fc? receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosusMERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients
P2860
Q21195675-9D701B7B-B140-4698-B3A1-0D728851A36FQ26766411-98C6FA39-0AB0-432D-8B22-02A0283259A8Q31108384-A8F66604-B45D-4DBB-904F-0C43D49283CAQ33338360-761C40CA-2BFC-43BC-91EA-EC65A334CBEDQ33402336-DC1FD255-5546-4A30-B29C-E530FE3898C4Q33697484-BA94EDE6-BB39-42AC-928A-4B71A8E22B72Q33932528-C97B5B6E-EE1A-46E7-ADF8-D13BD36D118EQ33976200-3D88F6D0-AA68-452E-AAD9-108655D81D5CQ34051976-8DC19F59-618E-4F20-B4EC-EA8BBFAE3789Q34148175-FAB4E09A-8989-4A52-9F47-523F40BAE976Q34153866-4CCBC07E-673E-40FF-A0DC-2CAF5C555952Q35171894-68D0DAC3-CBD8-491C-AD2B-A4F58BE8BF49Q35216982-5A086311-CD9C-488E-870B-B88683AC1DC7Q35551137-9458FFA7-93B9-46CE-9324-330F01F8F507Q35551931-93F0EC0F-67CF-459A-B201-6CFE35C26696Q35552018-DE53B13D-4E1A-44E9-A78B-0F0ADB16E767Q35804473-74D785AB-0447-407B-9272-F76667C54419Q35812595-E97BEC81-1BE7-4B92-BF9C-42EB0D57B318Q35814437-941426AA-FC96-47DD-9017-697732A72447Q37866353-7C47D98C-DC16-4340-BDDD-A514260E1E5AQ38290181-611E5FBF-7970-4020-BE86-43FF4F232BC4Q39763737-B97D0A76-160C-4342-92D3-63253BCC3657Q40773545-F5281595-12A1-4896-826A-DCAC91081020Q44904917-0405341D-EA71-44FC-A336-5CDA17F174B0Q44998018-18522817-EE38-4199-AB92-30F824B09858Q45025924-336A2A56-F5CC-4EF5-B756-4911ABDEF18FQ46010634-FED9060E-731E-44F6-9380-D8A3C698EC3BQ56906331-369E0E98-820D-4D9F-9466-2EC2E000D1C5Q57089544-91FD7C89-086A-42B3-BC4A-EB806924F2A9Q57329945-9DA8EEAF-4826-4FA5-A463-7DE23219ED8BQ57330808-6965B8ED-0792-4C2D-A63E-6910710D09F9
P2860
Fcgamma receptor IIa polymorphism in Caucasian patients with systemic lupus erythematosus: association with clinical symptoms.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@en
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@nl
type
label
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@en
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@nl
prefLabel
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@en
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@nl
P2093
P2860
P1476
Fcgamma receptor IIa polymorph ...... iation with clinical symptoms.
@en
P2093
Spriewald BM
Wassmuth R
Westerdaal NA
P2860
P304
P356
10.1002/1529-0131(199807)41:7<1181::AID-ART6>3.0.CO;2-C
P577
1998-07-01T00:00:00Z